Direct-to-consumer (DTC) genetic testing means exactly what it sounds like: you order the test yourself, without a doctor or genetic counselor as an intermediary in the ordering or initial interpretation process. Clinical-grade genetic testing is ordered by, or through, a licensed healthcare provider and performed in a laboratory that meets specific federal quality and certification standards. Both can use identical underlying sequencing technology — the difference is regulatory and procedural, not necessarily about the raw chemistry of the test itself.
What CLIA and CAP Actually Certify
| Standard | What it covers | Required for DTC labs? |
|---|---|---|
| CLIA (Clinical Laboratory Improvement Amendments) | Federal quality standards for lab testing, personnel qualifications, and quality control processes | Not required, though some DTC labs voluntarily obtain it |
| CAP (College of American Pathologists) | Additional, more detailed accreditation on top of CLIA, considered a higher bar | Voluntary |
| FDA | Reviews specific test claims for validity where it chooses to exercise oversight | Some DTC tests have FDA clearance for specific claims; many operate under enforcement discretion |
Importantly, CLIA certification addresses whether a lab's processes are technically sound and reproducible — it doesn't by itself certify that a specific genetic claim is clinically valid or useful for medical decision-making. That's a separate question the FDA sometimes weighs in on for specific test claims, and it's why even an FDA-cleared DTC test typically comes with explicit language that results shouldn't be used alone to make treatment or diagnostic decisions without consulting a healthcare provider.
Why This Distinction Actually Matters
A CLIA-certified, CAP-accredited clinical lab has been independently audited for accuracy, reproducibility, and quality control on a recurring basis — typically inspected every couple of years as part of maintaining accreditation. A DTC lab without those credentials may still produce accurate results, but there's less independent verification standing behind that claim, and DTC results have historically had a higher documented rate of requiring clinical confirmation before being acted on medically — which is exactly why major medical genetics organizations recommend retesting any medically significant DTC finding in a CLIA-certified lab before using it to guide a healthcare decision.
For curiosity, ancestry, and general wellness insight, DTC testing is a reasonable, accessible option. For anything that could change a medical decision — starting or stopping a medication, pursuing preventive surgery, making a major family planning decision — a positive or concerning DTC finding should be confirmed through a CLIA-certified clinical lab, ideally with a genetic counselor involved, before you act on it.
Where Whole Genome Sequencing Fits
Comprehensive WGS from a reputable provider generally sits closer to the higher-quality end of the DTC spectrum in terms of the depth and completeness of underlying data — but the CLIA/CAP distinction is about laboratory process certification, not sequencing depth, so it's still worth asking any provider directly about their certification status and their policy on clinical confirmation for medically actionable findings.
Get Comprehensive Data, Confirm What Matters Clinically
Dante Labs' whole genome sequencing gives you the most complete consumer genetic picture available — pair any medically significant finding with a genetic counselor before acting on it. Use code GENOME for 10% off.
Get Sequenced with Dante Labs → 10% off with code GENOMEFor help finding a genetic counselor to confirm and interpret significant findings, see our complete guide to genetic testing before having kids, which links directly to the NSGC and ABGC counselor directories.